Related Experiment Video
Updated: Jul 9, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
[Cerebral imaging and physiopathology of Alzheimer's disease]
Marine Fouquet1, Nicolas Villain, Gaël Chételat
1Inserm E0218, EPHE, Université de Caen Basse-Normandie, GIP Cyceron, CHU Côte de Nacre, Caen, France.
Abstract:
Alzheimer's disease (AD) is characterised by macroscopic cerebral damages which can be studied in vivo with neuroimaging techniques, even at the earliest stage. Studies were conducted in patients with amnestic Mild Cognitive Impairment (MCI) who best represent incipient AD. Right temporo-parietal hypometabolism, assessed by resting-state (18)FDG-PET, distinguishes patients who further develop AD from those who remain stable. From the pre-dementia stage of MCI, atrophy of the hippocampal region detected with structural MRI contrasts with functional alteration of the posterior cingulate gyrus measured with (18)FDG-PET and SPECT. Results from resting-state fMRI confirm this pattern of functional abnormalities and highlight changes in the hippocampal region functional connectivity, decreased with the posterior cingulate region, and increased with some frontal areas. Altogether with a structural connectivity impairment highlighted by DTI, those results support the hypothesis of a dysconnexion between the hippocampal and the posterior cingulate regions. Finally, activation fMRI data support the hypothesis of a functional compensation involving not only the frontal cortex but also, at the pre-dementia stage, the hippocampal region. Thus, this synthesis focuses on the hypotheses of dysconnexion and functional compensation, suggested to explain the discrepancies between the structural and functional alteration patterns, as well as on relevant results from resting-state fMRI, DTI and activation fMRI studies. Furthermore, this synthesis emphasizes the relevance of neuroimaging for the early detection of AD.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Dementia l: Introduction
Alzheimer's Disease: Treatment